Details for 2015865213

Up to date per 03.04.2026

Actions

Title / Product Name

ACTIVIN-ACTRII-ANTAGONISTEN UND VERWENDUNGEN DAVON ZUR BEHANDLUNG VON MYELODYSPLASTISCHEM SYNDROM

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015865213

EP Publication Number

3227675

E-Number

1553611

Language

PCT Number

US15063595

Publication Date

11.10.2017 A

15.03.2023 B1

Registration Date

15.03.2023

AT Publication Date

15.04.2023

Application Date

03.12.2015

Registration Number

Priorities

03.12.2014

201462086977 P

05.12.2014

201462088478 P

28.04.2015

201562153872 P

10.06.2015

201562173782 P

15.09.2015

201562218728 P

IPC

A61K 38/17 20060101AFI20220831BHEP

Maximum Duration of Protection

03.12.2035

Owner

Celgene Corporation86 Morris Avenue Summit, NJ 07901US

Acceleron Pharma Inc.128 Sidney Street Cambridge, MA 02139US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

ATTIE, Kenneth M.228 Marlborough Street Boston, MA 02116US

ROVALDI, Christopher24 Orchard Road Swampscott, MA 01907US

LAADEM, Abderrahmane12 Matthews Farm Road Belle Mead, NJ 08502US

Information about Fees